CHEN Chun, ZENG Kang-hui. Review of Adjuvant Atezolizumab After Adjuvant Chemotherapy in Resected StageⅠB~ⅢA Non-Small-Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2022, 22(1): 30-33. DOI: 10.12019/j.issn.1671-5144.2022.01.007
|
Citation:
|
CHEN Chun, ZENG Kang-hui. Review of Adjuvant Atezolizumab After Adjuvant Chemotherapy in Resected StageⅠB~ⅢA Non-Small-Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2022, 22(1): 30-33. DOI: 10.12019/j.issn.1671-5144.2022.01.007
|
CHEN Chun, ZENG Kang-hui. Review of Adjuvant Atezolizumab After Adjuvant Chemotherapy in Resected StageⅠB~ⅢA Non-Small-Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2022, 22(1): 30-33. DOI: 10.12019/j.issn.1671-5144.2022.01.007
|
Citation:
|
CHEN Chun, ZENG Kang-hui. Review of Adjuvant Atezolizumab After Adjuvant Chemotherapy in Resected StageⅠB~ⅢA Non-Small-Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2022, 22(1): 30-33. DOI: 10.12019/j.issn.1671-5144.2022.01.007
|
DownLoad: